Rethinking antibiotics by Helen I. Zgurskaya
BOOK REVIEW
published: 24 February 2015
doi: 10.3389/fmicb.2015.00132
Rethinking antibiotics
Helen I. Zgurskaya*
Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA
*Correspondence: elenaz@ou.edu
Edited by:
Jose L. Martinez, Centro Nacional de Biotecnología, Spain
Reviewed by:
Antonio Oliver, Hospital Son Dureta, Spain
Keywords: antibiotics, resistance, persisters, natural products, antimicrobial drug discovery and development
A book review on
Antibiotics: Current Innovations and Future Trends
Edited by S. Sanchez and A. L. Demain, Caister Academic Press, 2015, 430 pages
INTRODUCTIONS
In the past 50 years, antibiotics became
an important part of our everyday lives:
we take them during routine visits to den-
tal and doctor offices, but they are also
invisibly present on supermarket produce
shelves. If asked around, one would prob-
ably hear as many definitions of the word
“antibiotic” as there are uses for these
powerful drugs. However, this everyday
presence was recently interrupted by more
and more alarming news that these “mir-
acle drugs” that saved millions of lives
stopped working as expected. Antibiotic
resistance became a matter of public news
and executive orders of governments. The
urgency of tackling antibiotic resistance
requires actions from everyone. The new
book “Antibiotics: Current Innovations
and Future Trends” edited by Sergio
Sanchez and Arnold L. Demain takes a
fresh look at antibiotics as we know them
and explores what we can do to pre-
serve existing antibiotics and to secure
the present and the future of modern
medicine.
WHAT ARE ANTIBIOTICS?
The book comprises 21 articles written
by leading scientists on various aspects
of antibiotic uses, activities, discovery
and alternatives. Although the articles are
unrelated, they are assembled in such a
way as to truly engage a reader into the
world of antibiotics. The starting article
by Joan Wennstrom Bennett follows the
history of defining “antibiotics” beginning
with the “comprehensive” definition by
Selman Waxman that an antibiotic is
“. . . a chemical substance produced by
micro-organisms... to inhibit the growth
of and even to destroy bacteria and
other microorganisms. . . .” The subse-
quent chapters effectively demonstrate
that the field of antibiotics has over-grown
this definition and that medical uses of
antibiotics include not only infectious dis-
eases caused by micro-organisms but also
oncological diseases (Chapter 2 by Ren
and co-authors) as well as diseases caused
by multicellular parasites (Chapter 9 by
Shiomi and Omura) and viruses (Chapter
18 by Veiga-Crespo et al.). Non-medical
uses are even more diverse and some-
times are troubling for example, feed-
ing animals for growth, spraying flow-
ers and fruits to preserve freshness and
water treatments (Chapter 8 by Kardos).
Although microorganisms remain to be
major suppliers of antibiotics, present
days these microorganisms come from
new sources such as endophytes, geyz-
ers and caves (Chapters 10–12). Even un-
culturable micro-organisms are success-
fully “hunted” for new antibiotics (Lewis
et al, Chapter 6). Animal venoms and
plants also proved to be rich sources of
peptides and small molecules with antibi-
otic properties (Samy et al., Chapter 13).
HOW CANWE EXPAND THE DIVERSITY
OF ANTIBIOTICS?
The empirical search for natural products
in new and diverse places yielded most
of the antibiotics that are currently used
in medical and non-medical applications.
This approach continues to expand the
chemical diversity and biological activi-
ties of antibiotics. In addition, the book
analyzes how more analytical approaches
impact the drug discovery process and
what we can expect in the future from
these newest trends. Advances in DNA
sequencing and genomics as well as in
basic sciences impacted the drug discov-
ery process in several major ways: (i)
drug screening is re-focused from phe-
notypes onto specific targets (Chapter
14 by Lynn Silver); (ii) silent secondary
metabolic pathways are identified from
genome analyses and there are several
ways to activate them (Chapter 15 by
Martin and Liras); (iii) among various
genome treasures are new enzymatic activ-
ities needed for combinatorial biosyn-
thesis to generate novel bioactive com-
pounds (Chapter 16 by Park and Yoon).
Although some of these newest trends
did not live up to high expectations—
e.g., target focused screening was largely
unproductive—they also suggested alter-
natives and solutions. Significant num-
ber of new antibiotics are currently in
the development and clinical pipelines
(Chapter 21 by Park and Thomas). Novel
screening approaches focused on iden-
tification of pro-drugs effective against
persisters, compounds acting on several
homologous enzymes or pathways, efflux
pump inhibitors, anti-virulence targets
and pathogen specific vaccines all have a
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strong potential to expand the diversity
and effectiveness of antibiotics.
HOW CANWE PRESERVE THE
EXISTING ACTIVITIES?
The book does not specifically address
the problem of resistance or mechanisms
underlying the development and spread
of antibiotic resistance. However, resis-
tance affects and changes the entire field of
antibiotics starting with the drug discov-
ery process through the development and
applications and is invariably present in
almost all chapters. Undoubtedly, the mis-
use and overuse of antibiotics are major
contributors to development and spread of
resistance (Chapter 8 by Nelson Kardos). I
would like to briefly re-cite for the read-
ers the 2011 World Health Organization
advises on interventions to address this
growing problem: (i) lack of comprehen-
sive national actions; (ii) lack of capac-
ity and surveillance to choose adequate
treatment for individual patients andmake
policy decisions; (iii) overuse of antibiotics
for diseases that do not require them and
underuse due to insufficient dosing and
course durations; (iv) misuse of antibiotics
in food-producing animals for growth
promotion; (v) prevention of the spread
of resistant bacteria in hospitals and their
presence as environmental contaminants;
(vi) inadequate momentum in research
and development in the essential tech-
nologies. This book however demonstrates
that we are gaining significant momen-
tum in the essential technologies and
many of these interventions are already
in place. The major message is that only
acting on a global basis, we can preserve
antibiotics.
CONCLUSIONS
This book would be of interest to a broad
community of scientists, clinicians and
administrators working with antibiotics. It
could also be recommended as a textbook
for upper level undergraduate and grad-
uate classes at colleges and professional
schools.
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